J.P. Marvel Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.5M | Sell |
7,855
-137
| -2% | -$61K | 0.56% | 38 |
|
2025
Q1 | $3.87M | Buy |
7,992
+1,600
| +25% | +$776K | 0.67% | 38 |
|
2024
Q4 | $2.57M | Hold |
6,392
| – | – | 0.42% | 42 |
|
2024
Q3 | $2.97M | Hold |
6,392
| – | – | 0.49% | 44 |
|
2024
Q2 | $3M | Hold |
6,392
| – | – | 0.49% | 46 |
|
2024
Q1 | $2.67M | Buy |
6,392
+172
| +3% | +$71.9K | 0.46% | 47 |
|
2023
Q4 | $2.53M | Hold |
6,220
| – | – | 0.5% | 45 |
|
2023
Q3 | $2.16M | Hold |
6,220
| – | – | 0.47% | 45 |
|
2023
Q2 | $2.19M | Hold |
6,220
| – | – | 0.46% | 48 |
|
2023
Q1 | $1.96M | Hold |
6,220
| – | – | 0.44% | 50 |
|
2022
Q4 | $1.8M | Sell |
6,220
-5
| -0.1% | -$1.44K | 0.42% | 50 |
|
2022
Q3 | $1.8M | Hold |
6,225
| – | – | 0.46% | 49 |
|
2022
Q2 | $1.75M | Hold |
6,225
| – | – | 0.42% | 48 |
|
2022
Q1 | $1.63M | Buy |
6,225
+85
| +1% | +$22.2K | 0.33% | 53 |
|
2021
Q4 | $1.35M | Buy |
+6,140
| New | +$1.35M | 0.26% | 52 |
|